EMA postpones approval of Sputnik V vaccine, causes

The European Barnets Agency, The EMA will make the decision to approve Russian vaccine Sputnik V in the first three months of 2022, since the company estimates that the data so far is insufficient. The EMA decision by the end of the year is completely impossible”, a source for Reuters said. If the data [...]
The EMA decision by the end of the year is completely impossible”, a source for Reuters said.
If the required data arrives by the end of November, “then regulators can make a decision in the first quarter of next year”, added a source that wanted to remain anonymous.
EMA launched an official test of the Russian vaccine in March. Previously, it was expected to be approved in May or June.
The results of the third phase of clinical trials, published in February in The Lancet, showed that the vaccine was almost 92 percent effective. Russia later announced that it has 83 percent effectiveness against the delta version of the virus, the mutation that dominates the world today.











